{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:54:04Z","timestamp":1770814444220,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier","isbn-type":[{"value":"9780443473623","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.pmbts.2025.08.001","type":"book-chapter","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:43:31Z","timestamp":1757519011000},"page":"93-106","source":"Crossref","is-referenced-by-count":0,"title":["Cell-free systems for vaccine production"],"prefix":"10.1016","author":[{"given":"Nhat","family":"Le Bui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanh Linh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Phan Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Nhi","family":"Khuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinh-Toi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/bs.pmbts.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12257-020-0013-x","article-title":"Cell-free systems: recent advances and future outlook","volume":"25","author":"Koo","year":"2020","journal-title":"Biotechnol Bioprocess Eng."},{"issue":"7","key":"10.1016\/bs.pmbts.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.tibtech.2019.12.024","article-title":"Synthetic biochemistry: the bio-inspired cell-free approach to commodity chemical production","volume":"38","author":"Bowie","year":"2020","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/bs.pmbts.2025.08.001_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.biotechadv.2011.09.016","article-title":"Cell-free protein synthesis: applications come of age","volume":"30","author":"Carlson","year":"2012","journal-title":"Biotechnol Adv."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.synbio.2017.02.003","article-title":"Cell-free synthetic biology: engineering in an open world","volume":"2","author":"Lu","year":"2017","journal-title":"Synth Syst Biotechnol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fbioe.2020.00788","article-title":"Cell-Free systems: a proving ground for rational biodesign","volume":"8","author":"Laohakunakorn","year":"2020","journal-title":"Front Bioeng Biotechnol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/mps2010024","article-title":"A user\u2019s guide to cell-free protein synthesis","volume":"2","author":"Gregorio","year":"2019","journal-title":"Methods Protoc."},{"issue":"6","key":"10.1016\/bs.pmbts.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/acssynbio.8b00435","article-title":"Controlling secretion in artificial cells with a membrane AND gate","volume":"8","author":"Hilburger","year":"2019","journal-title":"ACS Synth Biol."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/acs.chemrev.4c00116","article-title":"Cell-free gene expression: methods and applications","volume":"125","author":"Hunt","year":"2025","journal-title":"Chem Rev."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fbioe.2020.00213","article-title":"Bottom-up construction of complex biomolecular systems with cell-free synthetic biology","volume":"8","author":"Laohakunakorn","year":"2020","journal-title":"Front Bioeng Biotechnol."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12915-019-0685-x","article-title":"Synthetic biology goes cell-free","volume":"17","author":"Tinafar","year":"2019","journal-title":"BMC Biol."},{"issue":"5","key":"10.1016\/bs.pmbts.2025.08.001_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.90","article-title":"Opportunities to accelerate extracellular vesicle research with cell-free synthetic biology","volume":"2","author":"Kelwick","year":"2023","journal-title":"J Extracell Biol."},{"issue":"12","key":"10.1016\/bs.pmbts.2025.08.001_bib12","article-title":"Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities","volume":"9","author":"Ghattas","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"34","key":"10.1016\/bs.pmbts.2025.08.001_bib13","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2022.03.032","article-title":"mRNA vaccines for COVID-19 and diverse diseases","volume":"345","author":"Hussain","year":"2022","journal-title":"J Control Rel."},{"issue":"2","key":"10.1016\/bs.pmbts.2025.08.001_bib15","article-title":"Vaccine safety issues at the turn of the 21st century","volume":"6","author":"Conklin","year":"2021","journal-title":"BMJ Glob Health."},{"issue":"4","key":"10.1016\/bs.pmbts.2025.08.001_bib16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/21645515.2018.1564437","article-title":"Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review","volume":"15","author":"Gualano","year":"2019","journal-title":"Hum Vaccin Immunother."},{"issue":"33","key":"10.1016\/bs.pmbts.2025.08.001_bib17","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing - an overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/bs.pmbts.2025.08.001_bib18","first-page":"44","article-title":"Vaccine manufacturing","volume":"4","author":"Gomez","year":"2013"},{"key":"10.1016\/bs.pmbts.2025.08.001_bib19","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107","author":"Vicente","year":"2011","journal-title":"J Invertebrate Pathol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib20","article-title":"Overview of cell-free protein synthesis: historic landmarks, commercial systems, and expanding applications","volume":"108","author":"Chong","year":"2014","journal-title":"Curr Protoc Mol Biol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2022.102888","article-title":"Cell-free protein synthesis systems for vaccine design and production","volume":"79","author":"Hu","year":"2023","journal-title":"Curr Opin Biotechnol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pr8060675","article-title":"The evolution of cell free biomanufacturing","volume":"8","author":"Vilkhovoy","year":"2020","journal-title":"Processes"},{"issue":"3","key":"10.1016\/bs.pmbts.2025.08.001_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40259-020-00417-y","article-title":"Cell-free protein synthesis: a promising option for future drug development","volume":"34","author":"Dondapati","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/bs.pmbts.2025.08.001_bib24","doi-asserted-by":"crossref","first-page":"15526","DOI":"10.1038\/ncomms15526","article-title":"A synthetic biochemistry platform for cell free production of monoterpenes from glucose","volume":"8","author":"Korman","year":"2017","journal-title":"Nat Commun."},{"issue":"4","key":"10.1016\/bs.pmbts.2025.08.001_bib25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cell.2014.10.004","article-title":"Paper-based synthetic gene networks","volume":"159","author":"Pardee","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/bs.pmbts.2025.08.001_bib26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cell.2016.04.059","article-title":"Rapid, low-cost detection of zika virus using programmable biomolecular components","volume":"165","author":"Pardee","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2025.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.699025","article-title":"Cell-Free glycoengineering of the recombinant SARS-CoV-2 spike glycoprotein","volume":"9","author":"Ruhnau","year":"2021","journal-title":"Front Bioeng Biotechnol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jbiotec.2019.05.011","article-title":"Detection of inorganic ions and organic molecules with cell-free biosensing systems","volume":"300","author":"Zhang","year":"2019","journal-title":"J Biotechnol."},{"issue":"5","key":"10.1016\/bs.pmbts.2025.08.001_bib29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/CVI.00496-09","article-title":"Efficacy of a potential trivalent vaccine based on hc fragments of botulinum toxins A, B, and e produced in a cell-free expression system","volume":"17","author":"Zichel","year":"2010","journal-title":"Clin Vaccine Immunol."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1308701110","article-title":"Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/bs.pmbts.2025.08.001_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096635","article-title":"A continuous-exchange cell-free protein synthesis system based on extracts from cultured insect cells","volume":"9","author":"Stech","year":"2014","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1016\/bs.pmbts.2025.08.001_bib32","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/bit.23103","article-title":"Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines","volume":"108","author":"Zawada","year":"2011","journal-title":"Biotechnol Bioeng."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acssynbio.2c00392","article-title":"A low-cost, thermostable, cell-free protein synthesis platform for on-demand production of conjugate vaccines","volume":"12","author":"Warfel","year":"2023","journal-title":"ACS Synth Biol"},{"issue":"36","key":"10.1016\/bs.pmbts.2025.08.001_bib34","doi-asserted-by":"crossref","first-page":"15121","DOI":"10.1074\/jbc.M117.784561","article-title":"Cell-free production of a functional oligomeric form of a chlamydia major outer-membrane protein (MOMP) for vaccine development","volume":"292","author":"He","year":"2017","journal-title":"J Biol Chem."},{"issue":"4","key":"10.1016\/bs.pmbts.2025.08.001_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/21655979.2016.1241925","article-title":"The growing impact of lyophilized cell-free protein expression systems","volume":"8","author":"Hunt","year":"2017","journal-title":"Bioengineered"},{"issue":"6","key":"10.1016\/bs.pmbts.2025.08.001_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe9444","article-title":"On-demand biomanufacturing of protective conjugate vaccines","volume":"7","author":"Stark","year":"2021","journal-title":"Sci Adv."},{"issue":"8","key":"10.1016\/bs.pmbts.2025.08.001_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat5105","article-title":"BioBits\u2122 explorer: a modular synthetic biology education kit","volume":"4","author":"Huang","year":"2018","journal-title":"Sci Adv."},{"issue":"8","key":"10.1016\/bs.pmbts.2025.08.001_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat5107","article-title":"BioBits\u2122 bright: a fluorescent synthetic biology education kit","volume":"4","author":"Stark","year":"2018","journal-title":"Sci Adv."},{"issue":"3","key":"10.1016\/bs.pmbts.2025.08.001_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.actatropica.2009.10.024","article-title":"The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery","volume":"114","author":"Tsuboi","year":"2010","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib40","doi-asserted-by":"crossref","first-page":"46086","DOI":"10.1038\/srep46086","article-title":"Immunoscreening of plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate","volume":"7","author":"Morita","year":"2017","journal-title":"Sci Rep."},{"issue":"36","key":"10.1016\/bs.pmbts.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"15121","DOI":"10.1074\/jbc.M117.784561","article-title":"Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development","volume":"292","author":"He","year":"2017","journal-title":"J Biol Chem."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib42","first-page":"2024","article-title":"Cell-free expression of Nipah virus transmembrane proteins for proteoliposome vaccine design","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/bs.pmbts.2025.08.001_bib43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.copbio.2013.02.008","article-title":"Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development","volume":"24","author":"Rodr\u00edguez-Limas","year":"2013","journal-title":"Curr Opin Biotechnol."},{"issue":"17","key":"10.1016\/bs.pmbts.2025.08.001_bib44","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/cbic.201500340","article-title":"Cell\u2010free protein synthesis: pros and cons of prokaryotic and eukaryotic systems","volume":"16","author":"Zemella","year":"2015","journal-title":"Chembiochem."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41467-018-05110-x","article-title":"Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery","volume":"9","author":"Jaroentomeechai","year":"2018","journal-title":"Nat Commun."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2022.102888","article-title":"Cell-free protein synthesis systems for vaccine design and production","volume":"79","author":"Hu","year":"2023","journal-title":"Curr Opin Biotechnol."},{"issue":"10","key":"10.1016\/bs.pmbts.2025.08.001_bib47","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41589-020-0595-9","article-title":"Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria","volume":"16","author":"Natarajan","year":"2020","journal-title":"Nat Chem Biol."},{"issue":"3","key":"10.1016\/bs.pmbts.2025.08.001_bib48","doi-asserted-by":"crossref","first-page":"1800271","DOI":"10.1002\/biot.201800271","article-title":"Endotoxin\u2010free E. coli\u2010based cell\u2010free protein synthesis: pre\u2010expression endotoxin removal approaches for on\u2010demand cancer therapeutic production","volume":"14","author":"Wilding","year":"2019","journal-title":"Biotechnol J."},{"issue":"6","key":"10.1016\/bs.pmbts.2025.08.001_bib49","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","article-title":"Novel approaches for vaccine development","volume":"184","author":"Gebre","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"2345940","DOI":"10.1080\/21645515.2024.2345940","article-title":"Exosome May be the next generation of promising cell-free vaccines","volume":"20","author":"Dai","year":"2024","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2020.102224","article-title":"Leveraging the wheat germ cell-free protein synthesis system to accelerate malaria vaccine development","volume":"80","author":"Kanoi","year":"2021","journal-title":"Parasitol Int."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jprot.2012.11.020","article-title":"Systematic analysis of natural antibody responses to P. Falciparum merozoite antigens by protein arrays","volume":"78","author":"Fan","year":"2013","journal-title":"J Proteom."},{"issue":"4","key":"10.1016\/bs.pmbts.2025.08.001_bib53","first-page":"327","article-title":"Virus like particles-A recent advancement in vaccine development","volume":"55","author":"Sarkar","year":"2019","journal-title":"Korean J Microbiol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib54","article-title":"Cell-free systems and genetic biosensors for accelerating enzyme and pathway prototyping","volume":"37","author":"Kim","year":"2024","journal-title":"Curr Opin Syst Biol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.csbj.2023.05.003","article-title":"Advancing synthetic biology through cell-free protein synthesis","volume":"21","author":"Yue","year":"2023","journal-title":"Comput Struct Biotechnol J."},{"issue":"9","key":"10.1016\/bs.pmbts.2025.08.001_bib56","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/acssynbio.8b00252","article-title":"Establishing a high-yielding cell-free protein synthesis platform derived from vibrio natriegens","volume":"7","author":"Des Soye","year":"2018","journal-title":"ACS Synth Biol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib57","doi-asserted-by":"crossref","first-page":"30399","DOI":"10.1038\/srep30399","article-title":"High-yield cell-free synthesis of human EGFR by IRES-mediated protein translation in a continuous exchange cell-free reaction format","volume":"6","author":"Quast","year":"2016","journal-title":"Sci Rep."},{"issue":"12","key":"10.1016\/bs.pmbts.2025.08.001_bib58","article-title":"Biotechnology applications of cell-free expression systems","volume":"11","author":"Brookwell","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/bs.pmbts.2025.08.001_bib59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.coche.2018.10.003","article-title":"Cell-free biomanufacturing","volume":"22","author":"Bundy","year":"2018","journal-title":"Curr Opin Chem Eng."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.copbio.2020.12.012","article-title":"Toward sustainable, cell-free biomanufacturing","volume":"69","author":"Rasor","year":"2021","journal-title":"Curr Opin Biotechnol."},{"issue":"4","key":"10.1016\/bs.pmbts.2025.08.001_bib61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12272-022-01381-7","article-title":"mRNA vaccines: the most recent clinical applications of synthetic mRNA","volume":"45","author":"Kwon","year":"2022","journal-title":"Arch Pharm Res."},{"issue":"1","key":"10.1016\/bs.pmbts.2025.08.001_bib62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cell.2016.09.013","article-title":"Portable, on-demand biomolecular manufacturing","volume":"167","author":"Pardee","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.pmbts.2025.08.001_bib63","article-title":"Prospects and challenges in developing mRNA vaccines for infectious diseases and oncogenic viruses","volume":"12","author":"Kutikuppala","year":"2024","journal-title":"Med Sci (Basel)"},{"issue":"15","key":"10.1016\/bs.pmbts.2025.08.001_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202688","article-title":"Polymer-based mRNA delivery strategies for advanced therapies","volume":"12","author":"Yang","year":"2023","journal-title":"Adv Healthc Mater."},{"issue":"2","key":"10.1016\/bs.pmbts.2025.08.001_bib65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/acssynbio.4c00729","article-title":"Cell-free systems to mimic and expand metabolism","volume":"14","author":"Rasor","year":"2025","journal-title":"ACS Synth Biol."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib66","doi-asserted-by":"crossref","unstructured":"Stark JC, et al. On-demand biomanufacturing of protective conjugate vaccines Sci Adv. 7(6): eabe9444.","DOI":"10.1126\/sciadv.abe9444"},{"issue":"46","key":"10.1016\/bs.pmbts.2025.08.001_bib67","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1016\/j.vaccine.2016.09.028","article-title":"Identification of plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate","volume":"34","author":"Ntege","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/bs.pmbts.2025.08.001_bib68","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/IAI.00690-13","article-title":"RALP1 is a rhoptry neck erythrocyte-binding protein of plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigen","volume":"81","author":"Ito","year":"2013","journal-title":"Infect Immun."},{"issue":"4","key":"10.1016\/bs.pmbts.2025.08.001_bib69","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.01539-07","article-title":"Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates","volume":"76","author":"Tsuboi","year":"2008","journal-title":"Infect Immun."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib70","first-page":"1","article-title":"Immunological characterization of plasmodium vivax Pv32, a novel predicted GPI-anchored merozoite surface protein","volume":"17","author":"Cheng","year":"2018","journal-title":"Malar"},{"issue":"100","key":"10.1016\/bs.pmbts.2025.08.001_bib71","doi-asserted-by":"crossref","DOI":"10.3791\/52772","article-title":"HeLa based cell free expression systems for expression of plasmodium rhoptry proteins","author":"Yadavalli","year":"2015","journal-title":"J Vis Exp."},{"key":"10.1016\/bs.pmbts.2025.08.001_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-018-0876-0","article-title":"Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate","volume":"17","author":"Bal","year":"2018","journal-title":"Microb Cell Fact."},{"issue":"8","key":"10.1016\/bs.pmbts.2025.08.001_bib73","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1182\/blood-2006-07-030593","article-title":"Cell-free production of scfv fusion proteins: an efficient approach for personalized lymphoma vaccines","volume":"109","author":"Kanter","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/bs.pmbts.2025.08.001_bib74","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/bit.24581","article-title":"Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens","volume":"109","author":"Welsh","year":"2012","journal-title":"Biotechnol Bioeng."}],"container-title":["Progress in Molecular Biology and Translational Science","Design and Applications of Cell-Free Systems Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117325001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117325001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:34:51Z","timestamp":1770798891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117325001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443473623"],"references-count":74,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2025.08.001","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}